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Abstract: The synthesis of Bsmoc-N-methyl amino acids is presented. The first step involves p-toluenesulfonic acid 
(TsOH) catalysed condensation of a Bsmoc-amino acid with paraformaldehyde to furnish N-Bsmoc-5-oxazolidinone un-
der MW irradiation. This intermediate is reduced to the corresponding N-methyl amino acid using triethylsilane (Et3SiH) 
and trifluoroacetic acid (TFA) at r.t. The N-methyl amino acids are converted into corresponding acid fluorides using di-
ethylaminosulfur trifluoride (DAST) and employed as coupling agents in the synthesis of dipeptides. The peptide coupling 
was mediated by KOAt in CH2Cl2. 
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INTRODUCTION 
 The N-methyl amino acids are wide spread in nature as 
part of larger peptidic natural products [1-3], alamethicin 
peptides and cyclosporine family [4]. They find broad appli-
cation in the design and development of biologically potent 
molecules in medicinal chemistry [5, 6]. In addition, they are 
inserted into biologically active peptides to enhance potency 
and duration of action or to convert an agonist to an antago-
nist or to obtain information about backbone conformation or 
to increase the aqueous solubility of a peptide [7]. For the 
purpose of peptide synthesis, it is essential to have N-
urethane protected N-methyl amino acids as building blocks. 
Several procedures are available for the synthesis of N-
carbamate protected N-methyl amino acids [8]. Benoiton 
procedure [9] involving NaH and MeI for abstraction of pro-
ton followed by methylation is the method of choice being 
utilized to prepare base stable Boc and Z protected N-methyl 
amino acids. An improvement has been made to the above 
method by using KH/18-crown ether and alkyl halide. Ben-
Ishai [10] demonstrated the first synthesis and utility of 5-
oxazolidinones as a tool for simultaneous protection of the 
amino and carboxyl groups. Recently, Sureshbabu et al. [11] 
demonstrated the utility of MW irradiation for the rapid, high 
yielding synthesis of 5-oxazolidinones. The entire protocol is 
complete in 2 min. Govender and Arvidsson [12] further fine 
tuned by selecting acetonitrile in place of toluene as a sol-
vent due to its poor dielectric heating capacity. Weinreb  
et al. [13] had developed a procedure for the reduction of 
methylol derivatives of simple amides using triethylsilane –  
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trifluoroacetic acid. This involves reduction of N-acylimi-
nium ion followed by ionic hydrogenation. Freidinger et al. 
[14] is the first one to synthesize Fmoc-N-methylated amino 
acids via 5-oxazolidinones and their reduction employing 
Et3SiH–TFA. This procedure was extended for the synthesis 
of N-methyl Trp, Asn, His and Arg and then to all other 
amino acids by Aurelio et al. [15,16]. Zhang et al. [17] ac-
complished the reductive ring opening of the 5-
oxazolidinone’s using Lewis acid catalysis (AlCl3 or ZnBr2). 
This paper deals with the hitherto unreported Bsmoc-N-
methyl amino acids synthesis employing Freidinger proce-
dure.  
 Bsmoc group [18] , introduced by Louis Carpino, for 
amino protection has significant advantages over the Fmoc 
group. The key difference of this invention is the mode of 
cleavage mechanism through Michael-like attack of base on 
?,? unsaturated sulfones [19] followed by elimination of CO2 
and amino component (Scheme 1). As Bsmoc group can be 
effectively cleaved with very low concentration of a weak 
base, its usage can circumvent several base catalyzed side 
reactions. Upon cleavage of the Fmoc group, the acidic 
phosphate buffer wash is necessary for the removal of DBF 
adduct formed. On the other hand, the use of either water or 
brine wash is sufficient for the complete removal of all by 
products formed in Bsmoc chemistry. This leads to a clear 
phase separation and minimal loss of carefully built peptide 
chain into aqueous phase. Ultimately, increase in yields of 
the target peptides can be achieved. The utility of Bsmoc 
group in rapid, continuous solution-phase peptide synthesis 
was demonstrated by the synthesis of a human parathyroid 
hormone fragment (hPTH, 21-29) [20]. The synthesis of pep-
tides employing acid fluorides is well known in peptide 
chemistry. In contrast to the corresponding acid chlorides, 
the acid fluorides have greater stability and are suitable for 
carrying out reactions bearing acid labile groups such as 
t
Bu, 
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Boc or trityl groups in the side chain [21]. Acid fluorides 
have been shown to accomplish difficult esterifications such 
as between a weakly nucleophilic secondary alcohol and a 
cyclohexyl amino acid, where other methods of activation 
such as DCC/DMAP, mixed anhydride, BOP-Cl or BOP 
have failed [22]. Successful synthesis of acyl carrier protein 
65-74 fragment (ACP), magainin-II-amide, human cortico-
tropin-releasing factor (h-CRF) and peptide related to Alz-
heimers disease A? (1-42) which are known as difficult se-
quences to synthesize, have been accomplished efficiently 
employing acid fluorides [23]. Very difficult sequence con-
taining sterically hindered C
??
-dialkylamino acids such as 
Aib [24], 1-aminocyclohexane-1-carboxylic acid and 4-
amino-piperidine-4-carboxylic acid [25] have also been 
achieved with greater efficiency by the use of corresponding 
acid fluorides. A comparative study of activation methods 
for the synthesis of the model tetrapeptide H-Aib-Aib-Aib-
Aib-OH by symmetric anhydride, PyBroP, acid fluoride and 
UNCA methods revealed that the acid fluoride coupling per-
form exceptionally well [26]. The acid fluorides are synthe-
sized using cyanuric fluoride in presence of pyridine accord-
ing to the general technique of Olah [27]. An alternative pro-
cedure for the synthesis of Fmoc-amino acid fluorides in-
volves DAST [28] which is advantageous owing to the for-
mation of water soluble byproducts, thus facilitating the iso-
lation of the acid fluorides. The synthesis of Bsmoc N-
methyl aminoacid fluorides using DAST and their coupling 
in the presence of KOAt is described.  
RESULTS AND DISCUSSION 
 Towards the first step, benzothiophene-2-methanol, pre-
pared using literature procedure, was oxidized using m-
chloroperbenzoic acid (m-CPBA) at r.t. A simple work up of 
the reaction resulted the sulfone in 88% yield. Earlier de-
scription of the oxidation involved in the use of excess of 
acetic acid and sodium perborate. During the preliminary 
rounds of preparation of sulfone we followed the reported 
protocol. In such crops, during the removal of acetic acid 
considerable amount of the product was decomposed result-
ing in low yield of sulfone. Treatment of 1,1-dioxo-
benzothiophene-2-methanol with triphosgene resulted in 
77% of Bsmoc-Cl (Scheme 2) which was then converted into 
its succinimide. Bsmoc- amino acids were prepared by the 
reported procedure .  
 For the synthesis of Bsmoc-amino acids, Bolin’s tech-
nique of N,O-bis-trimethyl amino acids was employed. 
Bsmoc-OSu was added to a solution of freshly prepared 
N,O-bis-trimethyl amino acid in DCM and the reaction mix-
ture was stirred at r.t. for 2 hr. Workup of the reaction mix-
ture resulted in Bsmoc amino acids in good yield (Scheme 
3).  
R = H, CH3, CH(CH3)2, CH2C6H5, 
      CH2CH(CH3)2, CH(C2H5)CH3
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Scheme 3. Synthesis of Bsmoc-amino acid. 
 The synthesis of Bsmoc-5-oxazolidinones was carried 
out starting from Bsmoc-amino acids. Bsmoc-amino acid 
was condensed with paraformaldehyde in presence of cata-
lytic amount of TsOH under microwave irradiation. The re-
action was complete within 3 min and workup of the reaction 
mixture resulted in 1a-f (Scheme 4, Table 1) in 89 to 95% 
yield. These oxazolidinones were stable at room temperature 
and had a strong IR stretching frequency at 1800 cm
-1
. Fur-
ther, the 
1
H NMR specta of the same also showed a signal in 
the vicinity of gamma amino alcohol ? 5.1 ppm which is the 
characteristic peak of 5-oxazolidinone.  
 The 5-oxazolidinones were reduced into their corre-
sponding N-methyl amino acids by treatment with 2.5 eq of 
Et3SiH in presence of TFA-CHCl3 (1:1). This has resulted in 
simultaneous ring opening along with reduction to obtain 
Bsmoc-NMe-amino acids 2a-f in 80 to 93% yield (Scheme 5, 
Table 2). The reaction was complete after stirring for 22 hr at 
r.t. The IR specta of Bsmoc-N-methyl amino acids showed 
the absence of IR stretching band at 1800 cm
-1 
corresponding 
to 5-oxazolidinones. The 
1
H NMR of Bsmoc-N-methyl 
S O
O
NHR
O O
N
H
S
O O
N
CO2 + Free peptide
elimination
S
O O
isomerization
N
stable water soluble adduct  
Scheme 1. Cleavage mechanism of Bsmoc group. 
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Scheme 2. Synthesis of Bsmoc-Cl. 
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Scheme 4. Synthesis of Bsmoc -5-oxazolidinones. 
Table 1. List of Bsmoc-5-Oxazolidinones 
Entry Bsmoc-5-oxazolidinones 
R 
Yield
* 
(%) 
IR 
(cm
-1 
) 
M.P. 
(
o
C) 
[?]25D 
(C1, CHCl3) 
1a H 91 1801,1718 100-03 - 
1b CH3 93 1801,1720  Gum +79.8 
1c CH2C6H5 92 1799,1719  95-97 +91.9 
1d CH(CH3)CH2CH3 92 1799,1717  123-25 +74.8 
1e CH2 CH (CH3)2 95 1800,1720  40-42 +81.4 
1f CH (CH3)2 95  803,1720 120-22 +77.3 
*The reaction time was 3 minutes for all the entries 
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Scheme 5. Reduction of N-Bsmoc-5-oxazolidinones to N-methyl amino acids and convertion into corresponding acid fluorides. 
Table 2. List of Bsmoc-N-Methyl Amino Acids 
Entry Bsmoc-NMe-amino acids   Yield (%)  M.P. 
(
o
C) 
[?]25D  
(c 1, CHCl3) 
2a Bsmoc-Sar-OH 80 gum - 
2b Bsmoc-MeAla-OH 91 140-42 -27.9 
2c Bsmoc-MePhe-OH 89 95-97  -20.0 
2d Bsmoc-MeIle-OH 88 123-25 -31.5 
2e Bsmoc-MeLeu-OH 93 40-42 -26.8 
2f Bsmoc-MeVal-OH 92 105-08  -38.9 
 
amino acids showed the presence of singlet peak at around ? 
3.0 ppm pertaining to N-methyl protons.  
 On treatment of Bsmoc-N-methyl amino acids with 
DAST in DCM resulted in Bsmoc-N-methyl amino acid 
fluorides 3a-g in good yield (Scheme 5, Table 3). The IR 
analysis of acid fluorides showed a strong stretching absorp-
tion band at 1780 cm
-1
.  
 Potassium Salt of 7-Aza-1-hydroxybenzotriazole 
(KOAt), introduced by Sureshbabu and Gopi, was used to 
mediate the coupling of Bsmoc –N-methyl amino acids to 
prepare dipeptides (Scheme 6, Table 4). The coupling was 
carried out in CH2Cl2 at r.t. and was found be free from ra-
cemisation. All the isolated peptides were fully charactaer-
ized. In order to test susceptibility of the method towards 
racemization, the synthesis of two diastereomeric dipeptides 
Bsmoc-L-Phg-Phe-OMe and Bsmoc-D-Phg-Phe-OMe was 
carried out. Bsmoc-L or D-Phg-F was coupled with H2N-
Phe-OMe in presence of KOAt. The 
1
H NMR analysis of the 
two diastereomers revealed that the C-methyl doublets of the 
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dipeptides differed from each other and also the methyl ester 
singlet was separated (? 3,59; 3,66) by 0.07 ppm . Further, 
the HPLC studies of these dipeptides Bsmoc-L-Phg-Phe-
OMe (Rt value 9.7) and Bsmoc-D-Phg-Phe-OMe (Rt value 
10.7), synthesized by the present method, revealed that they 
are optically pure and the coupling is completely free from 
racemization. 
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R
N
O
3
KOAt/ DCM
OY
O
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Scheme 6. Synthesis of peptides.  
CONCLUSION 
 In summary, this paper describes the preparation of 
Bmoc-N-methyl amino acids in two step procedure. Key N-
Bsmoc-5-oxazolidinones have been isolated in good yields. 
The reduction of N-Bsmoc-5-oxazolidinones was carried 
using Et3SiH and TFA in CH2Cl2 at r.t. Bsmoc-N-methyl 
amino acid fluorides are prepared using DAST which are 
isolated in almost quantitative yield. The coupling of Bsmoc-
N-methyl amino acids was accomplished by KOAt success-
fully. 
EXPERIMENTAL PROCEDURES 
 All the reactions were monitored by TLC with precoated 
silica gel plates purchased from Merk. Column chromatog-
raphy was performed with Merk silica gel (100-240) at nor-
mal atmospheric pressure. The optical rotations were deter-
mined with an automatic digital AA-10 polarimeter (Optical 
activity, U.K). Analytical HPLC was performed on a Shima-
dzu Class VP- V6.1 with PDA detector; Column: Agilent 
Zorbax C-18, 250 x 4.0mm column; Mobile phase: CH3CN 
(65%) :: H2O (35%); Absorbance : 230 nm; flow rate : 1 
mL/min. 
1
H NMR was recorded on a Bruker AMX 400 MHz 
instrument with Me4Si as an internal standed. Mass spectra 
were recorded on Kratos PCKompact SEQ V1.2.2 spec-
trometer. 
General Procedure for the Synthesis of Bsmoc-Amino 
Acids  
 To a suspension of amino acid (5 mmol) in DCM (10 
mL), NMM (0.55 mL, 5 mmol) and TMS-Cl (0.9 mL, 12 
mmol) were added in one portion. The reaction mixture was 
refluxed for 2 hr and cooled in an ice bath. Bsmoc-OSu (1.29 
g, 5 mmol) was added at that temperature over a period of 10 
min. The reaction mixture was stirred for 1-1.5 hr at r.t. The 
solvent was removed in vacuo and the resulting oil was dis-
tributed between diethyl ether and 10% NaHCO3 solution. 
The combined aqueous layers were acidified to pH 2 with 
Table 3. List of the Acid Fluorides 
Entry Bsmoc-amino acids Yield 
(%) 
M.P. 
(
o
C) 
[?]25D  
(c 1, CHCl3) 
3a Bsmoc-Nva-F 89 70-72 -6.3 
3b Bsmoc-Sar-F 79 Gum - 
3c Bsmoc-MeAla-F - 140-42 -6.8 
3d Bsmoc-Me-Leu-F 91 Gum -11.5 
3e Bsmoc-Me-Ile-F 82 Gum -14.1 
3f Bsmoc-Me-Val-F 90 100-02  12.7 
3g Bsmoc-Me-Phe-F 89 110-02 -17.8 
 
Table 4. List of the Bsmoc Dipeptides 
Entry R R1 X Y Yield 
(%) 
Mass
1 
[M+Na]
+ 
4a CH2CH(CH3)2 CH3 H CH2C6H5 89 551.3 
4b CH3 CH2CH(CH3)2 H CH3 92 475.2 
4c (CH2)2CH3 H CH3 CH3 91 461.2 
4d CH2CH(CH3)2 CH2CH(CH3)2 CH3 CH3 89 531.3 
4e CH (CH3)2 (CH2)2CH3 CH3 CH3 87 503.1 
4f CH2CH(CH3)2 CH(CH3)2 CH3 CH3 85 517.1 
4g CH2C6H5 CH (CH3)CH2CH3 CH3 CH3 89 565.2 
1 MS [MALDI-TOF] 
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conc HCl and the resulting Bsmoc-amino acids was ex-
tracted with ethyl acetate (10 mL X 3 times). The combined 
organic layer was washed with water (20 mL X 3 times) and 
dried over anhydrous Na2SO4. Evaporation of the solvent in 
vacuo and recrystallization of the resulting residue from 
DCM: n-hexane (1:1) gave Bsmoc-amino acids in good 
yield. 
General Procedure for the Synthesis of Bsmoc-5-
Oxazolidinones 1a-f: 
 A slurry of Bsmoc-amino acid (10 mmol), paraformalde-
hyde (2 g) and p-TsOH (100 mg) in toluene (10 mL) was 
subjected to microwave irradiation in an unmodified domes-
tic microwave oven operating at 2450 MHz frequency at its 
full power. After completion of the reaction, the residue was 
diluted with CHCl3 (25 mL), washed with 10% aqueous Na-
HCO3 (10 mL X 3 times) and water (10 mL X 3 times). The 
organic layer was dried over anhydrous Na2SO4 and the sol-
vent was evaporated in vacuo to obtain the 5-oxazolidinones 
in almost quantitative yield.  
 Bsmoc-Ala-5-oxazolidinone 1b. 
1
H NMR (400MHz, 
CDCl3): ? (ppm) = 1.29 (d, J= 6.7, 3H), 3.92 (m, 1H), 4.54 
(s, 2H), 5.17 (s, 2H), 7.20-7.80 (m, 5H); 
13
C NMR (100 
MHz, CDCl3) 18.2, 55.3, 65.9, 71.2, 120.8, 122.2, 123.1, 
127.5, 130.1, 132.2, 137.5, 139.3, 159.2, 169.1; ES-MS Cald 
for C14H13NO6S m/z: 324.3 [M+1]
+
, found: 324.3 [M+1]
+
.
 
 Bsmoc-Phe-5-oxazolidinone 1c. 
1
H NMR (400MHz, 
CDCl3): ? (ppm) = 2.85-3.05 (m, 2H), 4.50 (s, 2H), 4.65 (m, 
1H), 5.21 (s, 2H), 7.15-7.95 (m, 10H); 
13
C NMR (100 MHz, 
CDCl3) 31.2, 57.5, 69.0, 72.5, 120.5, 122.4, 123.1, 123.9, 
124.6, 125.3, 126.1, 127.1, 127.5, 130.1, 132.2, 137.2, 137.5, 
139.3, 162.2, 170.1; ES-MS Cald for C20H17NO6S m/z: 400.4 
[M+1]
+
, found: 400.3 [M+1]
+ 
.  
 Bsmoc-Ile-5-oxazolidinone 1d. 
1
H NMR (400MHz, 
CDCl3): ? (ppm) = 0.86-1.05 (m, 6H), 1.59-1.63 (m, 3H), 
4.56 (s, 2H), 4.70 (m, 1H), 5.20 (s, 2H), 7.20-7.85 (m, 5H); 
13
C NMR (100 MHz, CDCl3) 14.2, 17.5, 27.0, 35.1, 66.5, 
69.8, 75.5, 120.7, 122.8, 123.9, 124.6, 126.1, 130.1, 137.2, 
162.2, 170.1; ES-MS Cald for C20H17NO6S m/z: 400.4 
[M+1]
+
, found: 400.3 [M+1]
+ 
.  
 Bsmoc-Leu-5-oxazolidinone 1e. 
1
H NMR (400MHz, 
CDCl3): ? (ppm) = 0.95 (m, 6H), 1.29-1.53 (m, 3H), 4.60 (s, 
2H), 4.75 (m, 1H), 5.25 (s, 2H), 7.18-7.80 (m, 5H); 
13
C 
NMR (100 MHz, CDCl3) 14.2, 17.5, 27.0, 35.1, 66.5, 69.8, 
75.5, 120.7, 122.8, 123.9, 124.6, 126.1, 130.1, 137.2, 162.2, 
170.1; ES-MS Cald for C17H19NO6S m/z: 366.4 [M+1]
+
, 
found: 366.3 [M+1]
+ 
.  
 Bsmoc-Val-5-oxazolidinone 1f. 
1
H NMR (400MHz, 
CDCl3): ? (ppm) = 1.15 (d, J= 6.7, 6H), 1.71-1.80 (m, 1H), 
4.10 (m, 1H), 4.55 (s, 2H), 5.15 (s, 2H), 7.21-7.80 (m, 5H); 
13
C NMR (100 MHz, CDCl3) 21.1, 21.3, 27.6, 65.5, 70.1, 
79.2, 120.4, 122.9, 124.0, 126.1, 127.2, 129.1, 130.5, 138.2, 
162.5, 171.1; ES-MS Cald for C16H17NO6S m/z: 352.4 
[M+1]
+
, found: 352.4 [M+1]
+ 
. 
General Procedure for the Synthesis of Bsmoc-N-Methyl 
Amino Acids 2a-f: 
 Bsmoc-5-oxazolidinone (10 mmol) was dissolved in 
CHCl3 (15 mL). To this solution was added TFA (15 mL) 
and Et3SiH (3 mL) and stirred at r.t. for 24 hr. After comple-
tion of the reaction mixture, it was concentrated in vacuo and 
the residue was portioned between ether (20 mL) and 10% 
aqueous NaHCO3 (20 mL). The combined aqueous layer was 
acidified with concentrated HCl and extracted with EtOAc 
(10 mL X 3 times). The combined organic layer was washed 
with water (30 mL) and dried over anhydrous NaSO4. 
Evaporation of the solvent resulted in Bsmoc-N-methyl 
amino acids in good yield.  
 Bsmoc-Sar-OH 2a. 
1
H NMR ( 400MHz, CDCl3): ? 
(ppm) = 3.02 (s, 3H), 3.60 (s, 2H), 5.25 (s, 2H), 7.25-7.82 
(m, 5H); 
13
C NMR (100 MHz, CDCl3) 32.5, 55.2, 67.5, 
119.1, 120.7, 121.5, 126.8, 130.1, 132.2, 137.6, 139.8, 152.2, 
172.2; ES-MS Cald for C13H13NO6S m/z: 311.1 [M+1]
+
, 
found: 312.2 [M+1]
+
.
 
 Bsmoc-MeAla-OH 2b.
 1
H NMR (400MHz, CDCl3): ? 
(ppm) = 1.29 (d, J= 6.7, 3H), 2.98 (s, 3H), 4.35 (m, 1H), 5.21 
(s, 2H), 7.15-7.70 (m, 5H); 
13
C NMR (100 MHz, CDCl3) 
15.1, 35.1, 55.9, 69.2, 119.5, 123.5, 126.1, 126.9, 129.5, 
132.5, 138.1, 138.9, 160.5, 172.1; ES-MS Cald for 
C14H15NO6S m/z: 325.1 [M+1]
+
, found: 326.3 [M+1]
+
. 
 Bsmoc-MePhe-OH 2c. 
1
H NMR (400MHz, CDCl3): ? 
(ppm) = 3.00 (s, 3H), 3.21 (m, 2H), 4.25 (m, 1H), 5.30 (s, 
2H), 7.10-7.95 (m, 10H); 
13
C NMR (100 MHz, CDCl3) 32.1, 
33.8, 59.7, 69.0, 119.5, 120.9, 121.5, 121.4, 122.7, 122.9, 
123.4, 125.9, 126.1, 129.0, 131.9, 132.0, 132.6, 159.2, 174.1; 
ES-MS Cald for C20H19NO6S m/z: 401.1 [M+1]
+
, found: 
402.2 [M+1]
+ 
.  
 Bsmoc-MeIle-OH 2d. 
1
H NMR (400MHz, CDCl3): ? 
(ppm) = 0.85-1.15 (m, 8H), 2.25 (m, 1H), 2.95 (s, 3H), 4.45 
(m, 1H), 5.10 (s, 2H), 7.20-7.85 (m, 5H); 
13
C NMR (100 
MHz, CDCl3) 13.2, 16.6, 26.9, 33.0, 62.5, 67.8, 121.4, 121.9, 
125.4, 127.2, 128.0, 129.5, 131.1, 138.1, 159.0, 173.1; ES-
MS Cald for C17H21NO6S m/z: 367.1 [M+1]
+
, found: 368.0 
[M+1]
+ 
.  
 Bsmoc-MeLeu-OH 2e.
 1
H NMR (400MHz, CDCl3): ? 
(ppm) = 0.92 (d, J=6.7, 6H), 1.29 (m, 2H), 2.10 (m, 1H), 
3.00 (s, 3H), 4.20 (m, 1H), 5.17 (s, 2H), 7.18-7.80 (m, 5H); 
13
C NMR (100 MHz, CDCl3) 18.2, 22.0, 27.1, 33.7, 65.5, 
67.8, 121.0, 122.7, 123.1, 123.9, 127.7, 133.2, 135.6, 137.2, 
165.2, 172.4; ES-MS Cald for C17H21NO6S m/z: 367.1 
[M+1]
+
, found: 368.4 [M+1]
+ 
.  
 Bsmoc-MeVal-OH 2f. 
1
H NMR (400MHz, CDCl3): ? 
(ppm) = 0.95 (d, J= 6.7, 6H), 2.22 (m, 1H), 2.98 (s, 3H), 4.35 
(m, 1H), 5.15 (s, 2H), 7.21-7.75 (m, 5H); 
13
C NMR (100 
MHz, CDCl3) 15.3, 29.2, 33.3, 67.3, 72.1, 121.1, 122.0, 
123.4, 125.9, 129.0, 132.1, 132.9, 133.4, 165.5, 173.7; ES-
MS Cald for C16H19NO6S m/z: 353.1 [M+1]
+
, found: 354.3 
[M+1]
+ 
. 
Bsmoc-N-Methyl Amino Acid Fluorides 3a-g: 
 To a suspension of Bsmoc-N-methyl amino acid (1 
mmol) in DCM (5 mL) was added DAST (0.2 mL, 1.5 
mmole) under nitrogen and stirred for an hr at r.t. After the 
completion of the reaction, it was further diluted with DCM 
(10 mL) and washed with cold water (10 mL X 2 times). The 
solvent was dried over anhydrous Na2SO4 and was evapo-
rated under reduced pressure to result in a residue which was 
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recrystallized using DCM: n-hexane to yield Bsmoc-amino 
acid fluorides as solids. 
General Procedure for the Coupling of Bsmoc-N-Methyl 
Amino Acid Fluorides Mediated by KOAt 4a-g 
 To a stirred solution of Bsmoc-N-methyl amino acid 
fluoride (2 mmole) and KOAt (1.1 mmole) in dry DCM (5 
mL) was added a solution of amino free amino acid ester in 
dry DCM (5 mL) and the reaction mixture was stirred at r.t. 
The progress of the reaction was monitored by TLC. After 
the completion of the reaction, it was concentrated and the 
resulting residue was diluted with CH2Cl2 (10 mL), washed 
thrice with 5 mL portions of 5% HCl, 5% NaHCO3 and water 
and dried over anhydrous Na2SO4. Evaporation of the sol-
vent in vacuo and recrystallization of the residue from 
CH2Cl2: petroleum ether mixture (1:3) yielded the peptide. 
 Bsmoc-Nmethyl-Leu-Ala-OBzl 4a. 
1
H NMR (400 MHz, 
CDCl3): ? (ppm) = 0.82-1.08 (m, 6H), 1.31 (d, J=5.9 Hz, 
3H), 1.51(m, 2H), 1.72 (m, 1H), 2.98 (s, 3H), 4.49 (m, 1H), 
4.68 (m, 1H), 4.97-5.28 (m, 3H), 5.35 (s, 2H), 7.32-7.77 (m, 
10H); MS (MALDI-TOF) calcd. for C27H32N2O7S m/z: 551.2 
[M + Na]
+
, 567.7 [M + K]
+
, found: 551.3 [M + Na]
+
, 567.5 
[M + K]
+
; Anal. Calcd for C27H32N2O7S (%): C, 61.34; H, 
6.10; N, 5.29; found: C, 61.21; H, 6.01; N, 5.14.  
 Bsmoc-NMeVal-Leu-OMe 4b. 
1
H NMR (400 MHz, 
CDCl3): ? (ppm) = 0.89- 1.05 (m, 6H), 1.35 (d, J=5.7, 3H), 
1.55-1.75 (m, 3H), 3.00 (s, 3H), 3.60 (s, 3H), 4.54 (m, 1H) 
5.13-5.29 (m, 3H), 6.32 (br, 1H), 7.35-7.80 (m, 4H) MS 
(MALDI-TOF) calcd. for C21H28N2O7S m/z: 475.2 [M + 
Na]
+
, 491.1 [M + K]
+
, found: 475.2 [M + Na]
+
, 491.1 [M + 
K]
+
.
 
 Bsmoc-Nva-Sar-OMe 4c. 
1
H NMR (400 MHz, CDCl3): 
? (ppm) = 0.85 (t, J= 6.7, 3H), 1.32-167 (m, 4H), 2.97 (s, 
3H), 3.01 (s, 3H), 3.65 (s, 3H) 4.24 (m, 1H), 5.17 (s, 2H), 
5.65 (m, 1H), 7.30-7.79 (m, 4H); MS (MALDI-TOF) calcd. 
for C20H26N2O7S m/z: 461.1 [M + Na]
+
, 477.1 [M + K]
+
, 
found: 461.2 [M + Na]
+
, 477.1 [M + K]
+
. 
 Bsmoc-NMeLeu-NMeLeu-OMe 4d. 
1
H NMR (400 
MHz, CDCl3): ? (ppm) = 0.85- 1.01 (m, 12H), 1.27-1.39 (m, 
3H), 1.52-1.76 (m, 3H), 2.95 (s, 3H), 3.01 (s, 3H), 3.63 (s, 
3H), 4.92 (m, 1H) 5.12 (m, 1H), 5.20 (s, 2H), 7.35-7.77 (m, 
4H); MS (MALDI-TOF) calcd. for C25H36N2O7S m/z: 531.2 
[M + Na]
+
, 547.2 [M + K]
+
, found: 531.3 [M + Na]
+
, 547.0 
[M + K]
+
. 
 Bsmoc-NMeVal-Nva-OMe 4e. 
1
H NMR (400 MHz, 
CDCl3): ? (ppm) = 0.89 (t, J=5.9, 3H), 1.15-1.45 (m, 10H), 
1.97 (m, 1H), 2.97 (s, 3H), 3.05 (s, 3H), 3.67 (s, 3H), 4.74 
(m, 1H) 5.35 (m, 1H), 5.18 (s, 2H), 7.30-7.75 (m, 4H); MS 
(MALDI-TOF) calcd. for C23H32N2O7S m/z: 503.2 [M + 
Na]
+
, 519.2 [M + K]
+
, found: 503.1 [M + Na]
+
, 519.1 [M + 
K]
+
. 
 Bsmoc-NMeLeu-NMeVal-OMe 4f. 
1
H NMR (400 
MHz, CDCl3): ? (ppm) = 0.85- 1.02 (m, 6H), 1.32 (m, 2H), 
1.47-1.68 (m, 7H), 1.85 (m, 1H), 2.95 (s, 3H), 3.02 (s, 3H), 
3.60 (s, 3H), 4.52 (m, 1H) 5.65 (m, 1H), 5.17 (s, 2H), 7.29-
7.77 (m, 4H); MS (MALDI-TOF) calcd. for C24H34N2O7S 
m/z: 517.2 [M + Na]
+
, 533.2 [M + K]
+
, found: 517.1 [M + 
Na]
+
, 533.3 [M + K]
+
. 
 Bsmoc-NMePhe-NMeIle-OMe 4g. 
1
H NMR (400 MHz, 
CDCl3): ? (ppm) = 1.01-1.27 (m, 8H), 1.56 (m, 1H), 2.72 (m, 
2H), 2.97 (s, 3H), 3.00 (s, 3H), 3.67 (s, 3H), 4.67 (m, 1H) 
5.32 (m, 1H), 5.20 (s, 2H), 7.19-7.89 (m, 10H); MS 
(MALDI-TOF) calcd. for C28H34N2O7S m/z: 565.2 [M + 
Na]
+
, 581.2 [M + K]
+
, found: 565.2 [M + Na]
+
, 581.1 [M + 
K]
+
. 
Racemization Studies were Carried Out by Preparing 
Following Compounds 
Bsmoc-L-Phg-Phe-OMe 
 To a stirred solution of Bsmoc-Phg-F (0.75 g, 2 mmoles) 
and KOAt (0.38 g, 2.2 mmoles) in dry DCM (5 mL) was 
added a solution of H2N-Phe-OMe (0.36 g, 2 mmoles) dis-
solved in dry DCM (5 mL). The reaction mixture was stirred 
for 30 min at r.t. and its workup, following the general pro-
cedure yielded the dipeptide as a white crystalline solid (0.93 
g, 88%); m. p. 125-27
o
C; TLC Rf (EtOAc : n-hexane :: 3:7), 
0.43; [?]25D -14.0o (c 0.5, DMF); 1H NMR (CDCl3): ? 2.9 
(2H, d), 3.64 (3H,s), 4.5 (1H, m), 5.10 (2H, d), 5.25 (1H, d), 
6.25 (2H, 2d), 7.1-7.8 (15 ArH , m). Anal. Calcd. for 
C28H26N2O7S1 (534.58): C, 62.91; H, 4.90; N, 5.24; found: 
C, 62.82; H, 4.81; N, 5.14. MS (MALDI-TOF): m/z calcd. 
557.5 [M + Na]
+
, 573.6 [M + K]
+
, found: 557.7 [M + Na]
+
, 
573.1 [M + K]
+
. 
Bsmoc-D-Phg-Phe-OMe 
 To a stirred solution of Bsmoc-D-Phg-F (0.75 g, 2 
mmoles) and KOAt (0.38 g, 2.2 mmoles) in dry DCM (5 
mL) was added a solution of H2N-Phe-OMe (0.36 g, 2 
mmoles) dissolved in dry DCM (5 mL). The reaction mix-
ture was stirred for 30 min at r.t. and its workup yielded the 
dipeptide as a white crystalline solid (0.95 g, 90%), m. p. 
127-30
o
C; TLC Rf (EtOAc : n-hexane :: 3:7), 0.45; [?]25D 
+14.4
o
 (c 0.5, DMF); 
1
H NMR (CDCl3): ? 3.0 (2H, d), 3.73 
(3H, s), 4.5 (1H, m), 5.10 (2H, d), 5.25 (1H, d), 6.25 (2H, 
two d), 7.1-7.8 (15 ArH , m). Anal. Calcd. for C28H26N2 O7S1 
(534.58): C, 62.91; H, 4.90; N, 5.24. found: C, 62.85; H, 
4.88; N, 5.16. MS (MALDI-TOF): m/z calcd. 557.5 [M + 
Na]
+
, 573.6 [M + K]
+
, found: 557.9 [M + Na]
+
, 573.5 [M + 
K]
+
. 
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